Episode 24 - Dr. Samuel Ewing and the New World of Digital Hospitals

The Future of Pharma

Sisällön tarjoaa Samir Gondalia, ISPE Boston, Samir Gondalia, and ISPE Boston. Samir Gondalia, ISPE Boston, Samir Gondalia, and ISPE Boston tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.

1M ago 36:42

MP3•Jakson koti

My guest in this episode is Dr. Samuel Ewing. He is the Global Head of Pharmaceutical Partnerships at Doccla.

Before joining Doccla, Dr. Ewing led the development of a connected auto-injector system for Roche’s Alzheimer’s disease program at Capgemini Engineering. He also led the development of Biofourmis’s wearable vital sign monitoring platform.

At Roche, he managed remote patient monitoring across various diseases, including Parkinson’s, Huntington’s, Alzheimer’s, Multiple Sclerosis, and others. As Chief Neuroscience Officer at NeuroPro, he developed a wearable brain monitoring device for epilepsy.

Dr. Ewing's extensive experience in digital health and medical research drives his commitment to advancing treatment for challenging diseases. He believes that the scarcity of data from patients in the real world hinders progress, something he is committed to overcoming.

In this fascinating chat, we talk about our current hospital systems, and capacity, and how patients can get the hospital care in the comfort of their home in a digital hospital.

Here’s my guest Dr. Samuel Ewing.

26 jaksoa

#Science #Fitness #Medicine #Samir Gondalia, ISPE Boston #ISPE Boston #Samir Gondalia #Boston #Gondalia #Healthcare #Innovation #Ispeboston #Pharma #Pharmaceutical #ISPE